Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

12.37
Delayed Data
As of Dec 02
 +0.27 / +2.23%
Today’s Change
10.52
Today|||52-Week Range
19.98
-26.59%
Year-to-Date
Retail, Financials, Speculative Biotechs Getting Hit
Nov 28 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close12.10
Today’s open12.10
Day’s range11.90 - 12.60
Volume1,131,702
Average volume (3 months)1,628,765
Market cap$1.9B
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-80.60%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book260.31

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...+0.57+1.00%
JUNOJuno Therapeutics In...+0.53+2.66%
RDUSRadius Health Inc+0.06+0.12%
AVXSAveXis Inc-1.25-2.20%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts


Search for Jobs